The Division of Pediatric Nuclear Medicine is a subspecialty service that is part of the Department of Radiology LPCH and is affiliated with the Stanford School of Medicine Division of Nuclear Medicine and Molecular Imaging in the Department of Radiology at Stanford School of Medicine.
Our department provides dedicated pediatric nuclear medicine and molecular imaging studies to children in the Palo Alto and San Francisco Bay area. We have within our department 2 state of the art gamma cameras to include a hybrid SPECT/CT camera, and a dual head SPECT gamma camera. In addition, we provide state of the art PET molecular imaging with a PET/MR camera. We provide the breadth of nuclear medicine and molecular imaging diagnostic studies that would image all organ systems to include, brain, MSK, GI, GU cardiac, pulmonary, endocrine, would cover diagnoses that might be congenital, neoplastic, traumatic, infectious, inflammatory, metabolic, vascular, iatrogenic.
Since the department opened at the end of 2017, we have performed over 700 PET MR studies including brain and whole body imaging. We perform a combination of hybrid molecular imaging techniques on standard nuclear medicine gamma cameras as well as PET/MR studies.
We also provide therapies for thyroid cancer, hyperthyroidism and high dose mIBG therapy for neuroblastoma and phaeochromocytoma. We have a dedicate inpatient therapy room in LPCH for inpatient therapy needs and work in consultation with the LPCH oncology department and endocrine department to provide these therapies. We hope to expand our therapy program to provide state of the art therapies for children as they become approved.
We also have a Pediatric Bone Densitometry program at LPCH Sunnyvale Outpatient Clinic and perform DXA studies in pediatric patients.